ATR-107
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
ATR-107 is a humanized monoclonal antibody inhibitor targeting interleukin-21 receptor (IL-21R) . It holds potential for research in autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog